Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA

Zacks 01:00

Glaukos Insider Sold Shares Worth $1,502,800, According to a Recent SEC Filing

MT NewswiresDec 24 17:14

Glaukos Seeks FDA Approval for Non-Invasive Keratoconus Therapy Epioxa

BenzingaDec 23 20:05

Express News | Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

BreakingsDec 23 20:00

The Three-year Returns Have Been Stellar for Glaukos (NYSE:GKOS) Shareholders Despite Underlying Losses Increasing

Yahoo FinanceDec 21 21:36

Is Glaukos (NYSE:GKOS) Weighed On By Its Debt Load?

Simply Wall StDec 21 20:06